Nature Reviews Drug Discovery

Scope, open access and whether your paper fits

Nature Reviews Drug Discovery is an economics, econometrics and finance journal published by Nature Portfolio since 1967. Below: what it publishes, its open-access status and citation figures from OpenAlex, and a short checklist for deciding whether to submit there.

Review my paper

Publisher
Nature Portfolio
Field
Economics, Econometrics and Finance · Economics and Econometrics
Access
Subscription
h-index
478
2-year mean citedness
15.40
Works indexed
6,881
ISSN-L
1474-1776

What it publishes

The topics Nature Reviews Drug Discovery publishes most on, according to OpenAlex:

  • Pharmaceutical Economics and Policy
  • Computational Drug Discovery Methods
  • Pharmaceutical industry and healthcare
  • Science, Research, and Medicine
  • Cancer Immunotherapy and Biomarkers
  • Intellectual Property and Patents
  • Immunotherapy and Immune Responses
  • Monoclonal and Polyclonal Antibodies Research

How much it publishes

YearWorks indexed in OpenAlex
2026198
2025241
2024244
2023244
2022243
2021247

The latest year may be incomplete while indexing catches up.

Is your paper a fit?

  • Read the aims and scope on the journal’s own site: OpenAlex topics describe what it has published, not what it wants next.
  • Look at the titles of the last two issues: has it published work like yours recently?
  • Check the article types it accepts, word limits and any reporting checklist it requires.
  • Check your funder’s open-access rules: subscription journals may need a green or gold open-access route.
  • Compare it with similar journals below, and use the free journal finder to see where papers like yours were published.

About these figures

Data from OpenAlex (CC0), retrieved 2026-10-22. The h-index and 2-year mean citedness are computed by OpenAlex; 2-year mean citedness is similar in spirit to an impact factor but is not the Clarivate Journal Impact Factor. NoveltyAxis is not affiliated with this journal or its publisher.

Questions

Is Nature Reviews Drug Discovery open access?

Subscription. Fees change, so confirm on the journal’s site.

What is the h-index of Nature Reviews Drug Discovery?

478, according to OpenAlex: at least that many of its papers have each been cited at least that many times.

Is Nature Reviews Drug Discovery the right journal for my paper?

Only if your paper fits its scope and recent content. Run a pre-submission review to see whether the draft is ready, and the journal finder to compare where similar papers were published.